We are live on ! Find out more
MAP

Madison Avenue Partners Portfolio holdings

AUM $2.3B
1-Year Est. Return 115.82%
This Fund
S&P 500
This Quarter Est. Return
+4.67%
1 Year Est. Return
+115.82%
3 Year Est. Return
+241.12%
5 Year Est. Return
+319.41%
10 Year Est. Return
–
AUM
$1.5B
AUM Growth
+$320M
Cap. Flow
+$267M
Cap. Flow %
17.84%
Top 10 Hldgs %
83.78%
Holding
30
New
8
Increased
6
Reduced
8
Closed
4

Top Buys

Rank Stock Value
1
SNDK
Sandisk
SNDK
+$137M
2
GMED icon
Globus Medical
GMED
+$111M
3
LKFT
Lakefront Biotherapeutics American Depositary Shares
LKFT
+$50.3M
4
KROS icon
Keros Therapeutics
KROS
+$36.3M
5
MRP
Millrose Properties Inc
MRP
+$21.8M

Top Sells

Rank Stock Value
1
PCG icon
PG&E
PCG
+$50.7M
2
SOLV icon
Solventum
SOLV
+$40.3M
3
MKL icon
Markel Group
MKL
+$13.2M
4
SLRN
ACELYRIN
SLRN
+$10.2M
5
NNI icon
Nelnet
NNI
+$10M

Sector Composition

Rank Sector Weight
1 Healthcare 44.49%
2 Industrials 15.54%
3 Financials 12.41%
4 Technology 10.81%
5 Communication Services 8.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GHC icon
1
Graham Holdings Company
GHC
$4.97B
$232M 15.49%
245,271
– –
SOLV icon
2
Solventum
SOLV
$13.5B
$170M 11.36%
2,244,344
-568,673
-20% -$40.3M
MKL icon
3
Markel Group
MKL
$25B
$168M 11.24%
84,310
-7,047
-8% -$13.2M
SNDK
4
Sandisk
SNDK
$213B
$162M 10.81%
+3,571,109
New +$137M
INDV icon
5
Indivior Pharmaceuticals
INDV
$4.79B
$117M 7.8%
7,922,178
+130,089
+2% +$1.52M
TBPH icon
6
Theravance Biopharma
TBPH
$874M
$105M 7%
9,511,150
– –
GMED icon
7
Globus Medical
GMED
$10.4B
$101M 6.75%
+1,712,148
New +$111M
WLY icon
8
John Wiley & Sons Class A
WLY
$2.52B
$91.6M 6.12%
2,052,696
-155,370
-7% -$6.54M
SAGE
9
DELISTED
Sage Therapeutics
SAGE
$55.4M 3.7%
6,077,065
+1,599,267
+36% +$11.8M
LKFT
10
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.82B
$52.5M 3.51%
+1,877,011
New +$50.3M
MAGN
11
Magnera Corp
MAGN
$488M
$40.4M 2.7%
3,344,005
– –
STGW icon
12
Stagwell
STGW
$1.84B
$36.1M 2.41%
8,014,322
+866,660
+12% +$4.36M
KROS icon
13
Keros Therapeutics
KROS
$199M
$35.9M 2.4%
+2,691,465
New +$36.3M
INVX
14
Innovex International
INVX
$1.87B
$27.6M 1.84%
1,767,997
-645,611
-27% -$9.92M
MRP
15
Millrose Properties Inc
MRP
$4.74B
$23.5M 1.57%
+825,804
New +$21.8M
NNI icon
16
Nelnet
NNI
$4.79B
$17.5M 1.17%
144,214
-89,616
-38% -$10M
CRGX
17
DELISTED
CARGO Therapeutics
CRGX
$17.3M 1.15%
4,193,626
+4,092,674
+4,054% +$17.5M
CNNE icon
18
Cannae Holdings
CNNE
$647M
$14.1M 0.94%
674,250
+255,266
+61% +$4.72M
AIV
19
Aimco
AIV
$380M
$12.7M 0.85%
+1,473,826
New +$11.9M
ALMS
20
Alumis Inc
ALMS
$3.57B
$5.53M 0.37%
+1,842,269
New +$8.7M
FSP
21
Franklin Street Properties
FSP
$44.8M
$4.23M 0.28%
2,580,357
-153,061
-6% -$255K
ARVN icon
22
Arvinas
ARVN
$518M
$3.68M 0.25%
+500,000
New +$3.68M
PLRX icon
23
Pliant Therapeutics
PLRX
$67.5M
$2.59M 0.17%
2,230,012
+554,969
+33% +$784K
CMCO icon
24
Columbus McKinnon
CMCO
$465M
$702K 0.05%
45,961
-573,382
-93% -$8.76M
SN icon
25
SharkNinja
SN
$21B
$609K 0.04%
6,152
– –
1
2

Similar funds

LCM
Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return
LFM
LGT Fund Management Vaduz, Liechtenstein $2.3B AUM 22.66% 1-Year Est. Return
GCP
Greenoaks Capital Partners Orinda, California $2.3B AUM 19.87% 1-Year Est. Return
ST
Smithfield Trust Pittsburgh, Pennsylvania $2.3B AUM 14.87% 1-Year Est. Return
NSAM
North Star Asset Management Neenah, Wisconsin $2.31B AUM 10.09% 1-Year Est. Return
EPM
Elm Partners Management Philadelphia, Pennsylvania $2.31B AUM 16.02% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
ABI
Abrams Bison Investments Bethesda, Maryland $2.31B AUM 40.26% 1-Year Est. Return

Madison Avenue Partners's Q2 2025 Portfolio in Review

As of Q2 2025, Madison Avenue Partners held 30 positions worth $1.5B, up 27% from $1.18B the previous quarter. Its ten largest holdings account for 84% of the portfolio.

Madison Avenue Partners deployed $267M of net new capital in Q2 2025, opening 8 new positions and adding to 6 existing holdings. Its largest new stake was Sandisk: 3,571,109 shares worth $162M.

By sector, the portfolio is most concentrated in Healthcare at 44% of assets, up from 36% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Solventum, an estimated $40.3M trimmed.

  • Madison Avenue Partners's largest Q2 2025 buy was Sandisk: 3,571,109 shares worth $162M.
  • Madison Avenue Partners added most to CARGO Therapeutics in Q2 2025, an estimated $17.5M increase.
  • Madison Avenue Partners's biggest Q2 2025 reduction was Solventum, cutting an estimated $40.3M.
  • Madison Avenue Partners fully exited PG&E in Q2 2025, selling an estimated $50.7M.
  • Madison Avenue Partners's ten largest holdings make up 84% of its $1.5B portfolio in Q2 2025.
  • Madison Avenue Partners opened 8 new positions and closed 4 in Q2 2025.
  • Madison Avenue Partners's portfolio value rose 27% quarter-over-quarter to $1.5B.

Based on Madison Avenue Partners's 13F filing for Q2 2025, filed 14 Aug 2025.